154 related articles for article (PubMed ID: 32276581)
1. Increased Interleukin-35 suppresses peripheral CD14
Xing H; Tian G
BMC Immunol; 2020 Apr; 21(1):17. PubMed ID: 32276581
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease.
Sun M; Xing H
Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556
[TBL] [Abstract][Full Text] [Related]
3. [The regulatory activity of interleukin-35 on CD14
Yu HW; Dong YY; Dang YH
Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(20):1518-1522. PubMed ID: 34044520
[No Abstract] [Full Text] [Related]
4. Infliximab regulates monocytes and regulatory T cells in Kawasaki disease.
Koizumi K; Hoshiai M; Katsumata N; Toda T; Kise H; Hasebe Y; Kono Y; Sunaga Y; Yoshizawa M; Watanabe A; Kagami K; Abe M; Sugita K
Pediatr Int; 2018 Sep; 60(9):796-802. PubMed ID: 29543362
[TBL] [Abstract][Full Text] [Related]
5. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of circulating soluble CD14 in Kawasaki disease.
Takeshita S; Nakatani K; Tsujimoto H; Kawamura Y; Kawase H; Sekine I
Clin Exp Immunol; 2000 Feb; 119(2):376-81. PubMed ID: 10632678
[TBL] [Abstract][Full Text] [Related]
7. CD14+CD16+ monocyte subpopulation in Kawasaki disease.
Katayama K; Matsubara T; Fujiwara M; Koga M; Furukawa S
Clin Exp Immunol; 2000 Sep; 121(3):566-70. PubMed ID: 10971526
[TBL] [Abstract][Full Text] [Related]
8. Activin a suppresses peripheral CD8
Wu Q; Weng R; Xu Y; Wang L; Huang Y; Yang J
BMC Immunol; 2021 Feb; 22(1):17. PubMed ID: 33622252
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-7 promotes lung-resident CD14
Li S; Wang Z; Zhang G; Fu J; Zhang X
Int Immunopharmacol; 2019 Feb; 67():202-210. PubMed ID: 30557823
[TBL] [Abstract][Full Text] [Related]
10. The Interleukin-33/ST2 Axis Enhances Lung-Resident CD14+ Monocyte Function in Patients with Non-Small Cell Lung Cancer.
Wang L; Mei X; Liu X; Guo L; Yang B; Chen R
Immunol Invest; 2023 Jan; 52(1):67-82. PubMed ID: 36218388
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling suppresses CD14
Zhang ZH; Wang H; Zhang DN; Zhu GZ
APMIS; 2019 Sep; 127(9):642-652. PubMed ID: 31274210
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-35 Enhances Regulatory T Cell Function by Potentially Suppressing Their Transdifferentiation into a T Helper 17-Like Phenotype in Kawasaki Disease.
Li H; Xing H
Immunol Invest; 2023 Nov; 52(4):513-528. PubMed ID: 37052682
[TBL] [Abstract][Full Text] [Related]
13. Aberrant regulation of interleukin-12 receptor beta2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes.
Skarsvik S; Ludvigsson J; Vaarala O
Immunology; 2005 Feb; 114(2):287-93. PubMed ID: 15667574
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease.
Ichiyama T; Yoshitomi T; Nishikawa M; Fujiwara M; Matsubara T; Hayashi T; Furukawa S
Clin Immunol; 2001 Jun; 99(3):373-7. PubMed ID: 11358434
[TBL] [Abstract][Full Text] [Related]
15. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
[TBL] [Abstract][Full Text] [Related]
17. Plasma Exchange Downregulates Activated Monocytes and Restores Regulatory T Cells in Kawasaki Disease.
Koizumi K; Hoshiai M; Moriguchi T; Katsumata N; Toda T; Kise H; Hasebe Y; Kono Y; Sunaga Y; Yoshizawa M; Watanabe A; Harii N; Goto J; Kagami K; Abe M; Matsuda K; Sugita K
Ther Apher Dial; 2019 Feb; 23(1):92-98. PubMed ID: 30239141
[TBL] [Abstract][Full Text] [Related]
18. The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4(+) Th cells to promote the development of IL-22-secreting Th cells.
Baba N; Rubio M; Kenins L; Regairaz C; Woisetschlager M; Carballido JM; Sarfati M
Hum Immunol; 2012 Aug; 73(8):795-800. PubMed ID: 22609446
[TBL] [Abstract][Full Text] [Related]
19. CD14
Tsukamoto M; Seta N; Yoshimoto K; Suzuki K; Yamaoka K; Takeuchi T
Arthritis Res Ther; 2017 Feb; 19(1):28. PubMed ID: 28183329
[TBL] [Abstract][Full Text] [Related]
20. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
